2-202376511-A-AGGC
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001204.7(BMPR2):c.-930_-928dupGGC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.072 ( 387 hom., cov: 16)
Consequence
BMPR2
NM_001204.7 5_prime_UTR
NM_001204.7 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.67
Genes affected
BMPR2 (HGNC:1078): (bone morphogenetic protein receptor type 2) This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of two different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Mutations in this gene have been associated with primary pulmonary hypertension, both familial and fenfluramine-associated, and with pulmonary venoocclusive disease. [provided by RefSeq, May 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 2-202376511-A-AGGC is Benign according to our data. Variant chr2-202376511-A-AGGC is described in ClinVar as [Likely_benign]. Clinvar id is 333617.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0892 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0717 AC: 9008AN: 125692Hom.: 388 Cov.: 16 show subpopulations
GnomAD3 genomes
AF:
AC:
9008
AN:
125692
Hom.:
Cov.:
16
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0717 AC: 9017AN: 125796Hom.: 387 Cov.: 16 AF XY: 0.0682 AC XY: 4106AN XY: 60210 show subpopulations
GnomAD4 genome
AF:
AC:
9017
AN:
125796
Hom.:
Cov.:
16
AF XY:
AC XY:
4106
AN XY:
60210
Gnomad4 AFR
AF:
AC:
0.0652916
AN:
0.0652916
Gnomad4 AMR
AF:
AC:
0.0577183
AN:
0.0577183
Gnomad4 ASJ
AF:
AC:
0.0895101
AN:
0.0895101
Gnomad4 EAS
AF:
AC:
0.0843316
AN:
0.0843316
Gnomad4 SAS
AF:
AC:
0.0985724
AN:
0.0985724
Gnomad4 FIN
AF:
AC:
0.0465793
AN:
0.0465793
Gnomad4 NFE
AF:
AC:
0.0792753
AN:
0.0792753
Gnomad4 OTH
AF:
AC:
0.056051
AN:
0.056051
Heterozygous variant carriers
0
379
758
1136
1515
1894
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Nov 20, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Pulmonary hypertension, primary, 1 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at